JPWO2021258016A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021258016A5
JPWO2021258016A5 JP2022577426A JP2022577426A JPWO2021258016A5 JP WO2021258016 A5 JPWO2021258016 A5 JP WO2021258016A5 JP 2022577426 A JP2022577426 A JP 2022577426A JP 2022577426 A JP2022577426 A JP 2022577426A JP WO2021258016 A5 JPWO2021258016 A5 JP WO2021258016A5
Authority
JP
Japan
Prior art keywords
derived
car
cells
receptor
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022577426A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023530704A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/038134 external-priority patent/WO2021258016A1/fr
Publication of JP2023530704A publication Critical patent/JP2023530704A/ja
Publication of JPWO2021258016A5 publication Critical patent/JPWO2021258016A5/ja
Pending legal-status Critical Current

Links

JP2022577426A 2020-06-19 2021-06-18 免疫療法で使用するためのiPSC由来エフェクター細胞型の組み合わせ Pending JP2023530704A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063041672P 2020-06-19 2020-06-19
US63/041,672 2020-06-19
PCT/US2021/038134 WO2021258016A1 (fr) 2020-06-19 2021-06-18 Combinaison de types de cellules effectrices dérivées des ipsc pour leur utilisation en immunothérapie

Publications (2)

Publication Number Publication Date
JP2023530704A JP2023530704A (ja) 2023-07-19
JPWO2021258016A5 true JPWO2021258016A5 (fr) 2024-06-25

Family

ID=79025356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022577426A Pending JP2023530704A (ja) 2020-06-19 2021-06-18 免疫療法で使用するためのiPSC由来エフェクター細胞型の組み合わせ

Country Status (11)

Country Link
US (1) US20230235287A1 (fr)
EP (1) EP4168538A4 (fr)
JP (1) JP2023530704A (fr)
KR (1) KR20230040337A (fr)
CN (1) CN116096386A (fr)
AU (1) AU2021292695A1 (fr)
BR (1) BR112022025806A2 (fr)
CA (1) CA3182852A1 (fr)
IL (1) IL299106A (fr)
MX (1) MX2022015863A (fr)
WO (1) WO2021258016A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11661459B2 (en) 2020-12-03 2023-05-30 Century Therapeutics, Inc. Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
WO2022133169A1 (fr) * 2020-12-18 2022-06-23 Century Therapeutics, Inc. Systèmes récepteurs antigéniques chimériques ayant une spécificité de récepteur adaptable
AU2022423987A1 (en) * 2021-12-29 2024-07-11 Century Therapeutics, Inc. Genetically engineered cells having anti-cd19 / anti-cd22 chimeric antigen receptors, and uses thereof
WO2023200761A2 (fr) * 2022-04-11 2023-10-19 IN8bio, Inc. Lymphocytes t gamma-delta à base d'ipsc, compositions et leurs procédés d'utilisation
WO2023240212A2 (fr) * 2022-06-08 2023-12-14 Century Therapeutics, Inc. Cellules génétiquement modifiées ayant des récepteurs antigéniques chimériques anti-cd133/anti-cd22, et leurs utilisations
CN117305241B (zh) * 2023-11-28 2024-03-19 上海兴瑞一达生物科技有限公司 一种hiPSCs诱导分化为NK细胞的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3185368A1 (fr) * 2013-04-03 2014-10-09 Memorial Sloan-Kettering Cancer Center Generation efficace de lymphocytes t ciblant une tumeur derives de cellules souches pluripotentes
CN108368520B (zh) * 2015-11-04 2023-01-17 菲特治疗公司 多能细胞的基因组工程改造
CN111556892A (zh) * 2017-12-08 2020-08-18 菲特治疗公司 使用增强的iPSC衍生的效应细胞的免疫疗法
CN111542594A (zh) * 2017-12-22 2020-08-14 菲特治疗公司 增强的免疫效应细胞和其用途

Similar Documents

Publication Publication Date Title
JP2021505131A5 (fr)
US11414486B2 (en) Transgene genetic tags and methods of use
Zhukovsky et al. Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection
JPWO2021011919A5 (fr)
CA3032054A1 (fr) Polytherapies de recepteurs d'antigenes chimeriques adn inhibiteurs pd -1
EP3700926A1 (fr) Procédés de conception de cellules d'expression de récepteur antigénique chimérique
JPWO2019191495A5 (fr)
WO2020057641A1 (fr) Cellule exprimant la chimiokine et son utilisation
DK3029137T3 (en) GENETICALLY MODIFIED PLURI OR MULTIPOTENT STEM CELLS AND USE THEREOF
JP2021501587A (ja) Cd38指向性キメラ抗原受容体構築物
JP2024518011A (ja) 多様な免疫細胞のための単鎖および多鎖合成抗原受容体
IL295604A (en) Methods for producing cells expressing a chimeric antigen receptor
KR20230137923A (ko) 신규한 키메라 항원 수용체 및 이의 용도
EP4148125A1 (fr) Cellule immunitaire modifiée destinée à une allotransplantation
US20230242661A1 (en) Engineered immune cell expressing nk inhibitory molecule and use thereof
JPWO2021062281A5 (fr)
JPWO2020117526A5 (fr)
JPWO2021258016A5 (fr)
CN114015656A (zh) 用于同种异体移植的工程化免疫细胞
JPWO2021071962A5 (fr)
JPWO2021113744A5 (fr)
RU2822461C1 (ru) Трансгенные генетические метки и способы применения
CN117202921A (zh) 用于多种免疫细胞的单链和多链合成抗原受体
JPWO2020188570A5 (fr)